Curriculum vitae
Name: Iftikhar Khdhair Abbas Altemimi
Scientific position: Pathologist
Occupation Address: Kufa University/ medical college/ pathology department / Najaf/Iraq.
Place &date of birth: Najaf -Iraq 30-6-1983
Nationality: Iraqi
Religion: Muslim
Gender : Female
Marital status: Married & have 3 kids
Language: Arabic & English
Resident address: Al-Ghadeer residential dist. VIP B 7, house 14
E-Mail address: [email protected]
[email protected]
Mobile: 00964 7708041099
Academic qualification:
M.B.Ch.B. Kufa University /college of medicine (2001-2006).
F.I.C.M.S (Path) (2012-2016).
Appointment:
Jan 2007 house office doctor (rotator) Al- Zahra general hospital, Najaf.
Sep 2008 Al Sadr medical City, Najaf.
April 2009 senior house office doctor (resident) in pathology Kufa University / medical college /pathology department.
April 2011-2016 (post-graduation) senior house office doctor (resident) in pathology center at Al-Sadr medical City, Najaf (Iraqi board of medical specialty fellowship).
October 2016, Member of teaching staff in Kufa University / medical college /pathology
department.
8th November 2016 till 11th August 2020 involved in teaching process as lecturer.
8th October 2017 till 2021 start as Department Coordinator.
11th October 2017 till now start teaching in Jabir bin Haiyan university as volunteer
31st October 2017 till now start working for one day per week in Middle Euphrates Cancer Center.
22nd November 2017 till now join the Personal and Professional Development Program (PPDP) committee
11th August 2020 till now involved in teaching process as Assistant Professor, with master student supervision
Post-graduation study:
2011-2016 in kufa training center of pathology at Al Sadr medical City, Najaf.
2011 training at hematology, microbiology, biochemistry departments.
2012 training at cytology unit.
2013 training at immunohistochemistry unit.
2014-2015 postgraduation thesis.
Professional qualification:
Member of Iraqi medical Association 2007.
Member of Iraqi pathology Society (IPS) 2011.
Kufa University /medical college / member in ethical committee, Fab 2016.
Assessment committee in college of medicine/ Kufa university/ member 2017-2022
Department of pathology / scintefic committee /2022
Department of pathology / Post graduate committee /2023
Conferences & training:
13th -18th / March 2010 successfully completion of Oncology update course for Iraqi Doctors; Istanbul/Turkey.
28th -29th Nov/2010 Iraqi oncology summit; Beirut /Lebanon.
2 Nov-3 Nov 2012 1st BOA Baghdad congress (Best Of ASCO).
7th SEP – 9th SEP 2013 2nd BOA Baghdad congress (Best Of ASCO).
Oct 2013 participation in Iraqi summit ;Istanbul/Turkey
Sep 2014 training course in FISH ;Beirut /Lebanon
2016 Principle investigator of researches in Kufa Cancer research center/Kufa University /medical college.
11th November 2016 workshop in clinical investigators rsearch training program accredited by the center for Clinical Research at the Global Academy For Health Sciences And The University of Oxford / Beirut, Lebanon.
12th November 2016 successful completion of Good Clinical Practice in clinical research ( ICH- GCP) course accredited by the center for Clinical Research at the Global Academy For Health Sciences And The University of Oxford / Beirut, Lebanon.
25th july 2017 PD- L1 testing ( 22C3) Professional Expert course NSCLC / Cassel , Germany
16th – 18th December 2017 Ventana PD-L1 ( SP142) Assay workshop for pathologist for urothelial cancer and NSCLC / Dubai, UAE.
18th – 21st February 2018 Four days training program of pathology and radiology: TIME TO INTEGRATE/ 52352 hospital, Egypt.
18th -21st February 2018 the training course for medical doctors in the field of pathology "Pathology – Time to integrate" 57357 Health Care Sciences Academy, Egypt.
4th -5th March 2018 First Iraqi- Germany Conference of Medical Sciences at University of Babylon In Cooperation with Saint George Hospital, University of Leipzig.
16th January 2019 workshop Application of Moodle/ Kufa University, Iraq.
23rd March- 4th April 2019 Academic Leadership Program ( 60 hours ) for the enhancement of teaching, research, management and leadership skills of selected faculty members. College of medicine, Iraq.
6th -7th April 2019 First International Conference on Advanced Technologies of Cancer Diagnosis and Therapy ( ATCDT,19) / University of Kufa, Iraq.
21st -26th October 2019 Academic Leadership Program phase II ( 30 hours ) for the enhancement of teaching, research, management and leadership skills of selected faculty members. College of medicine, Iraq.
16th April 2020 MCQ Writing and Assignment on Moodle/ online workshop
E-Learning breaking time, space and pandemic as part of ITRDC online training program/ online course.
17th April 2020 Immunological Testing During COVID-19 Harvard Medical School is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physician/ virtual meet
21st April 2020 Let's Break the chain of COVID-19 Infection course as part of MBRU Community Immunity Ambassador Program/ Mohammed Bin Rashid, virtual course.
21st April 2020 Assessment in Medical Education/ online symposium.
14th May 2020 Features of the Research Gate and how to increase RG Score/ virtual workshop.
2nd June 2020 Molecular Cloning: Strategy and Application/ online workshop.
2nd June 2020 Principle of tissue culture and mesenchymal stem cells isolation/ free Conference Call
10th – 11th June 2020 Academic writing and publishing / Deanship of scientific Research, Kingdom of Saudi Arabia, online training course.
13th -14th June 2020 The First Virtual International Conference on COVID-19 Update/ Iraqi Medical Association, virtual conference.
4th July 2020 The SIVU Webner Series in Medical Education Online Assessment of Exams through Tele Presence.
International Symposium on COVID-19 home versus hospitalization doctors personal experience/ Iraqi Medical Association with collaboration of WHO, International and Iraqi Universities, virtual conference.
Second virtual International Conference on COVID-19: Containment and Living with/ Iraqi Medical Association with collaboration of WHO, International and Iraqi Universities, virtual conference.
November 24th 2021 online pathologist training workshop for PDL-1 assay in TNBC indication
December 21st 2021 online pathologist training workshop for PDL-1 SP142 assay in the NSCLC indication – Roche
24th oct 2022 patient centered care workshop-kufa university- college of medicine
23rd Apr 2023: Medical education series – Constructing communication skills curriculum (CSC)
15th -16th may 2023 pathologist training workshop Sheraton-Istanbul city center- Turkey
20th Nov 2023 Up to date management and pathological guidelines in breast cancer conference- Jabir Ibn Hayyan University
Researches and publication:
Human Papilloma Virus Expression in Iraqi Patients with Premalignant and Malignant Laryngeal Lesions: Immunohistochemical Study
• Published on: July 2019
• kufa journal for nursing sciences
The Correlation of Modified Marsh Grading System in Relation to Clinico pathological and Serological Assessment in Early Diagnosis of Celiac Disease
• Published on: September 2020
• Annals of Tropical Medicine and Public Health
Comparison of Molecular Subtypes Between Primary Breast Cancer and Its Metastatic Axillary Lymph Node(s)
• Published on: September 2020
• Annals of Tropical Medicine and Public Health
Loss of Immunohistochemical Expression of PTEN as a Predictive Biomarker in Breast Carcinoma
• Published on: January 2021
• European Journal of Molecular & Clinical Medicine
Has a Pleuroscopy Role in the Diagnosis of Unknown Cause Pleural Effusion a Single-Center Study
• Published on: December 2021
• Teikyo Medical Journal
Breast carcinoma primary tumors and synchronous axillaries lymph node(s) metastases may represent different malignant clones, although the daily clinical practice depends only on the molecular subtypes of primary tumor to select the adjuvant systemic treatment. In some instances the absence of primary tumor or presence of technical difficulties that prevent the identification of exact tumor subtypes in the primary mass mandate seeking for alternative to test. Aim: this paper aims to compare of molecular subtypes between primary tumor &metastatic lymph node(s). Method In this prospective cohort study, 50 patients with node positive breast carcinoma included. Immunohistochemical analysis by using Envision method for detection of biomarkers: ER, PR, Her2/neu and Ki-67 to determine the four molecular subtype then comparison between the primary tumor and its metastatic lymph node(s). Results: In this study there was 22 (44%) cases with luminal-A molecular subtype in both mass and lymph node, 21 (42%) cases with luminal-B in primary mass in comparison to 18 (36%) cases in their metastatic node, 3(6%) cases with Her2/neu enriched in the primary mass in comparison to 6(12%) cases in its metastatic node. There was 4 (8%) cases with triple negative molecular subtype which had no difference between them.. In Conclusions: There is no statistically significant difference between primary tumor and its metastatic lymph node(s) this concordance regarding the molecular subtypes may answer the question that pathologist can depends on the result of molecular subtypes on lymph node with good certainty if cannot do it on the primary tumor.
Background: Breast cancer is the most common malignancy with a high mortality in females worldwide. Tumor suppressor genes had significant role to maintain genome integrity and the cell cycle. In particular PTEN is a candidate tumor suppressor gene, It has a negative regulator of PI3K/AKT signaling pathway which has a major role in carcinogenesis and dysregulation of it occurs repeatedly in breast cancer. Aim: this article aimed to appraise the associations between PTEN expression in patient had breast cancer with clinic pathological parameters including: age, histological types, and status of estrogen receptor, progesterone receptor, and HER-2/nue receptor, to check the impact of its expression on clinical outcome. Materials and methods: in this case-control study, formalin fixed paraffin embedded tissue from sixty patients with breast carcinoma and twenty patients without cancer (as control groups). Labeled Streptavidin-Biotin (LSAB +) method used to detect PTEN protein expression, HER2/neu, ER and PR receptors by immunohistochemical assay, and then we correlate PTEN expression with each biomarkers and clinic pathological characteristics. Results: 29/60 (45.3%) of cases decreased PTEN expression while its expression retained in 31/60 (51%) of cases. Loss of expression significantly associated: with lymph node metastasis (p-value=0.0008), high grade (p< 0.05) , high stage (p-value=0.0001) and with triple negative breast cancer (p-value=0.03). However, loss of PTEN protein expression did not correlate with age, histological types, estrogen, progesterone and HER-2 receptors status. Conclusion: PTEN loss can predict aggressive behavior and worse outcome in patients had breast cancer.
Background: Celiac disease is an autoimmune disorder triggered by the ingestion of wheat gluten and relatedproteins of rye and barley in genetically susceptible individuals. Its diagnosis is based on clinical manifestations,endoscopic finding serological markers and histopathology Aims: to correlate the degree of mucosal damageaccording to modified Marsh grading system histopathological with clinical finding, endoscopy and serology.Methods: in this cross sectional study, one hundred patients included, for each one upper GIT endoscopy,microscopic examination of biopsy specimens from duodenum, serum anti tissue transglutaminase antibodies levelwere analyzed. Results: 83% of patient have tipical clinical feature of celiac disease but with accuracy (54.7%).Theupper intestinal endoscopy reveal (53 %) of cases had features of celiac disease, with accuracy of (84.1 %) morethan clinical finding in the diagnosis .A significant correlation (p value < 0.001) obtained between serum level ofanti tTG antibody and histopathology with sensitivity of (95.7%) and specificity of (91.8%). In addition there ispositive linear correlation between these two parameters (r=+0.942). Conclusion: Clinical presentations lackspecificity. Endoscopy has relatively good sensitivity and specificity. Serum level of anti-tTG antibody have highsensitivity and specificity therefore, it is reliable mean for prediction and diagnosis of celiac disease. (PDF) The correlation of modified Marsh grading system in relation to clinico pathological and serological assessment in early diagnosis of celiac disease. Available from: https://www.researchgate.net/publication/344754482_The_correlation_of_modified_Marsh_grading_system_in_relation_to_clinico_pathological_and_serological_assessment_in_early_diagnosis_of_celiac_disease [accessed Feb 22 2024].
pleuroscopy; pleural effusion; tuberculosis; adenocarcinoma In about 25-40% of pleural effusion cases not reached to diagnosis, so taking a pleural biopsy may decrease the number of cases with difficulty in diagnosis of pleural effusion. Using pleuroscopy has high accuracy in the diagnosis of these cases. It is safe with complications. In this study, 60 patients who underwent a pleural biopsy by pleuroscopy were studied with unknown causes of pleural effusion. The mean age was (51-/+13.2) and male to female ratio was 4 to 1. There were 36.6% of cases diagnosed with tuberculosis, 23.3% of cases diagnosed with adenocarcinoma. Pleuroscopy failed to reach a diagnosis in 16.6% only. So, the pleuroscopy yields high accuracy in the diagnosis of pleural effusion with unknown causes
Human Papilloma Virus is a DNA virus, epitheliotropic, non-enveloped, with a double strand circular genome, and about 8,000 pb, measuring 55 nm in diameter.Aim of study: Highlighting the relationship between the occurrence of premalignant laryngeal lesions and human papillomavirus like a causal factor together with development of laryngeal Squamous Cell Carcinoma.Methodology: Fifty cases of laryngeal cancer and premalignant laryngeal lesions are incorporated within this study. Tissues were saved within formaldehyde and embedded in paraffin blocks. We used Immunohistochemical technique in order to prove the correlat ion between HPV infection and those laryngeal lesions.
For first stage iraqi B
For PHD students
For Iraqi B students
PHD